Date | Time | Source | Headline | Symbol | Company |
12/04/2019 | 04:00 | Edgar (US Regulatory) | Confidential Treatment Order (ct Order) | NASDAQ:CASC | Cascadian Therapeutics, Inc. (delisted) |
23/05/2018 | 03:18 | Edgar (US Regulatory) | Confidential Treatment Order (ct Order) | NASDAQ:CASC | Cascadian Therapeutics, Inc. (delisted) |
10/04/2018 | 06:54 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:CASC | Cascadian Therapeutics, Inc. (delisted) |
23/03/2018 | 05:12 | Edgar (US Regulatory) | Termination of Registration of a Class of Security Under Section 12(b) (15-12b) | NASDAQ:CASC | Cascadian Therapeutics, Inc. (delisted) |
22/03/2018 | 21:01 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:CASC | Cascadian Therapeutics, Inc. (delisted) |
22/03/2018 | 21:01 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:CASC | Cascadian Therapeutics, Inc. (delisted) |
22/03/2018 | 21:01 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:CASC | Cascadian Therapeutics, Inc. (delisted) |
22/03/2018 | 21:01 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:CASC | Cascadian Therapeutics, Inc. (delisted) |
20/03/2018 | 06:17 | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (sc 13d/a) | NASDAQ:CASC | Cascadian Therapeutics, Inc. (delisted) |
14/03/2018 | 09:16 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CASC | Cascadian Therapeutics, Inc. (delisted) |
14/03/2018 | 09:12 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CASC | Cascadian Therapeutics, Inc. (delisted) |
14/03/2018 | 09:12 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CASC | Cascadian Therapeutics, Inc. (delisted) |
14/03/2018 | 09:12 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CASC | Cascadian Therapeutics, Inc. (delisted) |
14/03/2018 | 09:11 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CASC | Cascadian Therapeutics, Inc. (delisted) |
14/03/2018 | 09:11 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CASC | Cascadian Therapeutics, Inc. (delisted) |
14/03/2018 | 09:10 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CASC | Cascadian Therapeutics, Inc. (delisted) |
14/03/2018 | 09:10 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CASC | Cascadian Therapeutics, Inc. (delisted) |
14/03/2018 | 09:09 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CASC | Cascadian Therapeutics, Inc. (delisted) |
14/03/2018 | 09:09 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CASC | Cascadian Therapeutics, Inc. (delisted) |
14/03/2018 | 09:08 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CASC | Cascadian Therapeutics, Inc. (delisted) |
14/03/2018 | 09:08 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CASC | Cascadian Therapeutics, Inc. (delisted) |
14/03/2018 | 09:08 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CASC | Cascadian Therapeutics, Inc. (delisted) |
14/03/2018 | 09:08 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CASC | Cascadian Therapeutics, Inc. (delisted) |
14/03/2018 | 09:08 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CASC | Cascadian Therapeutics, Inc. (delisted) |
14/03/2018 | 09:08 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CASC | Cascadian Therapeutics, Inc. (delisted) |
14/03/2018 | 09:08 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CASC | Cascadian Therapeutics, Inc. (delisted) |
14/03/2018 | 09:07 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CASC | Cascadian Therapeutics, Inc. (delisted) |
14/03/2018 | 09:04 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CASC | Cascadian Therapeutics, Inc. (delisted) |
14/03/2018 | 09:03 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CASC | Cascadian Therapeutics, Inc. (delisted) |
14/03/2018 | 09:02 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CASC | Cascadian Therapeutics, Inc. (delisted) |